荷爾蒙治療藥物 – 安健腫瘤治療中心荷爾蒙治療藥物

What medications are used for hormone therapy?

Hormone therapy may be used to prevent the growth, spread, and recurrence of breast cancer. The female hormone estrogen can increase the growth of breast cancer cells in some women. Tamoxifen (Nolvadex®) is a medication used in hormone therapy to treat breast cancer by blocking the effects of estrogen on the growth of malignant cells in breast tissue.
However, tamoxifen does not stop the production of estrogen.

Hormone therapy may be considered for women whose breast cancers test positive for estrogen and progesterone receptors.

Drugs recently approved by the US Food and Drug Administration (FDA), called aromatase inhibitors, are used to prevent the recurrence of breast cancer in postmenopausal women. These drugs, such as anastrozole (Arimidex®) and letrozole (Femara®), prevent estrogen production. Anastrozole is effective only in women who have not had previous hormonal treatment for breast cancer. Letrozole is effective in women who have previously been treated with tamoxifen. Possible side effects of these drugs include osteoporosis or bone fractures.

Another new drug for recurrent breast cancer is fulvestrant (Faslodex®). Also approved by the FDA, this drug eliminates the estrogen receptor rather than blocking it, as is the case with tamoxifen, letrozole, or anastrozole. This drug is used following previous antiestrogen therapy. Side effects for fulvestrant include hot flashes, mild nausea, and fatigue.

Men who have breast cancer may also be treated with tamoxifen. Tamoxifen is currently being studied as a hormone therapy for treatment of other types of cancer.With prostate cancer, there may be a variety of medications used in hormone therapy. Male hormones, such as testosterone, stimulate prostate cancer to grow. Hormone therapy is given to help stop hormone production and to block the activity of the male hormones. Hormone therapy can cause a tumor to shrink and the prostate-specific antigen (PSA) levels to decrease.

返回頂部


立即與安健聯絡